Open Access. Powered by Scholars. Published by Universities.®

Cardiology Commons

Open Access. Powered by Scholars. Published by Universities.®

Journal

2020

COVID19

Articles 1 - 2 of 2

Full-Text Articles in Cardiology

Covid 19 Myocarditis: Myth Or Reality?, Lamyae Sasbou Md Sep 2020

Covid 19 Myocarditis: Myth Or Reality?, Lamyae Sasbou Md

Journal of the Saudi Heart Association

COVID 19 so far is not a known cardiotropic virus, and the term “myocarditis” should be exclusively used after EMB or autopsy proven diagnosis.

We report a case of 26-year-old man admitted for COVID 19 infection and symptoms leading to a myocarditis. We describe the workup that led to the potential diagnosis.


Hydroxychloroquine And Azithromycin As A Treatment Of Covid- 19: Electrocardiogram Variability, Amal El Ouarradi, Salma Abdeladim, Sara Oualim, Llham Bensahi, Sara Hafid, Hamza Tazi, Mahassine Elharras, Rita Aniq Filali, Abdelhamid Nailhou, El Arbi Bouaiti, Abdelhamid Moustaghfir, Mohamed Sabry Aug 2020

Hydroxychloroquine And Azithromycin As A Treatment Of Covid- 19: Electrocardiogram Variability, Amal El Ouarradi, Salma Abdeladim, Sara Oualim, Llham Bensahi, Sara Hafid, Hamza Tazi, Mahassine Elharras, Rita Aniq Filali, Abdelhamid Nailhou, El Arbi Bouaiti, Abdelhamid Moustaghfir, Mohamed Sabry

Journal of the Saudi Heart Association

During the COVID 19 pandemic, the effectiveness of the combination of hydroxychloroquine and azithromycin is widely discussed. This treatment can cause many severe cardiac side effects that makes us discuss its utility.

The aim of this study is to describe the cardiovascular effect of hydroxychloroquine and azithromycin by analyzing surface ECG in patients with COVID 19.

Methods: This observational cohort study included Moroccan patients with COVID 19 diagnosis and were hospitalized in Cheikh Khalifa International University Hospital, Casablanca, Morocco between March 26 and April 20, 2020.Patients were treated with a combination of hydroxychloroquine and azithromycin over a period of at …